SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-051105
Filing Date
2021-10-01
Accepted
2021-10-01 16:09:39
Documents
2
Period of Report
2021-09-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1573
2 POWER OF ATTORNEY ea148244ex24_jaspertherap.htm EX-24 6225
  Complete submission text file 0001213900-21-051105.txt   9271
Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Nolet Chris (Reporting) CIK: 0001782814 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211298969

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)